KCA 098

• Description:

  KCA 098 is an orally active benzofuroquinoline derivative. KCA 098 can inhibit bone resorption and stimulat bone formation of chick embryo. KCA 098 can increase calcium and phosphorus content as well as the amount of force required to break the femur from ovariectomized rats. KCA 098 can be used for the research of bone diseases[1].

• UNSPSC:

  12352005

• Target:

  Drug Derivative

• Related Pathways:

  Others

• Field of Research:

  Metabolic Disease

• Smiles:

  O=C(N(C)C)OC1=CC=C2C(OC(C3=C(N4)C=C(OC(N(C)C)=O)C=C3)=C2C4=O)=C1

• Molecular Formula:

  C21H19N3O6

• Molecular Weight:

  409.39

• References & Citations:

  [1]Kojima M, et al. Effect of KCA-098, a new benzofuroquinoline derivative, on bone mineral metabolism. Biol Pharm Bull. 1994 Apr;17 (4) :504-8.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [129794-24-7]